Search Within

Population Sciences Research Program

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (580)
  2. Journal Article (526)
  3. Research Letter (29)
  4. Review (18)
  5. Guidelines (10)
  6. Book Section (9)
  7. Correspondence (6)
  8. Editorial (6)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematologic Malignancies, Division of (1187)
  2. Department of Medicine (1186)
  3. Center for Hematologic Malignancies (1004)
  4. Lymphoma (720)
  5. Epidemiology and Biostatistics (483)
  6. Survivorship Research (471)

More Groups

People
  1. Steven Horwitz (645)
  2. Alison Moskowitz (220)
  3. Andrew Zelenetz (177)
  4. Paul Hamlin (141)
  5. Ariela Noy (139)
  6. Andriy Derkach (138)

More People

Years
  1. 2025 (26)
  2. 2024 (85)
  3. 2023 (130)
  4. 2022 (102)
  5. 2021 (101)
  6. 2020 (100)

More Years

Publications
  1. Blood (325)
  2. Journal of Clinical Oncology (159)
  3. Clinical Lymphoma, Myeloma and Leukemia (40)
  4. Hematological Oncology (38)
  5. Blood Advances (29)
  6. Leukemia and Lymphoma (27)

More Publications

Publishers
  1. American Society of Hematology (357)
  2. American Society of Clinical Oncology (169)
  3. Elsevier Inc. (87)
  4. Wiley Blackwell (70)
  5. Nature Publishing Group (59)
  6. American Association for Cancer Research (46)

More Publishers

Results (1187)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Feldman, T. A.; Ye, J. C.; Khodadoust, M. S.; Munoz, J.; Hamlin, P. A.; Kim, Y. H.; Wilcox, R. A.; Patel, M. R.; Coffey, G.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Case report: Decentralized trial of tolerability-adapted exercise therapy after severe COVID-19
    Journal Article

    Scott, J. M.; Qiu, Z.; Rahman, J.; Moskowitz, C. S.; Michalski, M. G.; Lehman, S.; Lee, C. P.; Harrison, J.; Yu, A. F.; Marouf, A.; more...
    Frontiers in Immunology (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save